drugset / Trial / NCT06454825
Effects of Antiemetic Agents in Orthognathic Surgery Patients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
In an effort to prevent or treat consistently high rates of PONV following maxillofacial operations, several medications, techniques and multimodal protocols have been studied. In the present study, the investigators hypothesized that combining metoclopramide with granisetron will improve PONV incidence when compared with granisetrone alone.
Timeline
- Start
- 2020-04-14
- Primary completion
- 2021-04-05
- Completion
- 2021-04-05
Outcome
Met primary endpoint
paper PONV scores at the second hour were 1.56 ± 1.45 in group G and 0.79 ± 0.90 in group GM (P = .03). PMID 39824505 ↗
paper Compared to granisetron alone, the combination of granisetron and metoclopramide was associated with significant PONV control PMID 39824505 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granisetron | Other / unclassified | 3 mg | Intravenous |
| Subject | Intravenous drug | Unknown | 10 mg | Intravenous |